Phase
Condition
Obsessive-compulsive Disorder
Kleptomania
Mood Disorders
Treatment
N/AClinical Study ID
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria :
Age 18 - 60
OCD according to DSM IV, at least 5 years since diagnosis
Severe OCD responsible for a clinically significant and objective alteration of psychosocial functioning and suffering: YBOCS score>25, CGI score >= 4 and EGF score <= 40
Resistance of OCD to at least 3 antidepressants from the serotonin reuptake inhibitors category, including clomipramine, given for at least 12 weeks with doses of at least 80mg/d for fluoxetine, 300mg/d for fluvoxamine, 200mg/d for sertraline, 60mg/d for paroxetine and citalopram, 250mg/d for clomipramine). Plus resistance to each of these 3 antidepressant associated first to risperidone or pimozide for a month then to Lithium carbonate, clonazepam, buspirone or pindolol for a month
Resistance to at least 2 behavioural and cognitive therapies conducted by as many different specialists, following validated protocols (e.g. exposition and prevention of response)
Oral and written knowledge of French
Social security coverage
Written consent of the patient after clear description of the study
Exclusion criteria :
cognitive alteration with PM38 score < IQ85
Other axis 1 disorder according to DSM IV, excepted, global anxiety disorder, social phobia, nicotine dependance, and antecedent of major depressive episodes
suicidal risk >=2 on item 10 of MADRS (Montgomery Asberg Depression Rating Scale)
Personality disorder (axis 2 of DSM IV assessed using the SCID II)
Contra indication to MRI, abnormal brain MRI, other severe intercurrent disease
Fertile woman without adequate contraception
Pregnancy
Forced psychiatric hospitalisation
Any kind of legal protection
Study Design
Study Description
Connect with a study center
Centre d'investigation Clinique Pitié Salpêtrière
Paris, 75013
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.